Bill > H0237

This bill amends Florida's existing law regarding the retail sale of ephedrine and related compounds by introducing a mandatory monthly fee for manufacturers of these substances. Starting July 1, 2025, manufacturers of ephedrine or related compounds sold in Florida must pay a fee to the administrator of an electronic recordkeeping system approved by the Department of Law Enforcement. The fee will be used to support the operation of this system, with the administrator setting the specific fee level for each manufacturer. Manufacturers will be required to provide written documentation of fee payment upon request by the Department of Law Enforcement. The bill also modifies penalty provisions to include violations of the new fee requirements, which can range from second-degree misdemeanors for first offenses to third-degree felonies for third or subsequent offenses. Ephedrine and related compounds are substances that can be used in the production of methamphetamine, and this bill aims to help fund and maintain a tracking system to monitor their distribution and prevent illegal use.

Justice

https://www.flsenate.gov/Session/Bill/2025/237